Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Together, these data demonstrate γ-secretase-mediated intramembranous proteolysis of TREM2 and functionally link two Alzheimer disease-associated proteins in one signaling pathway.
|
24078628 |
2013 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We analyzed RNA-Seq data from parietal lobe brain tissue from AD cases with TREM2 variants (n = 33), AD cases (n = 195) and healthy controls (n = 118), from three independent datasets using Kallisto and the R package tximport to determine the read count for each transcript and quantified transcript abundance as transcripts per million.
|
31068200 |
2019 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Alzheimer's Disease
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Our studies provide a first glimpse into the boost in myeloid cell function that can be achieved by pharmacological modulation of TREM2 activity that can potentially be ameliorative in neurodegenerative diseases such as Alzheimer's disease.
|
29599291 |
2018 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk.
|
26058841 |
2015 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, recent evidence-associated rare genetic variants of TREM2 gene with increased risk of Alzheimer's disease, frontotemporal dementia, amyotrophic lateral sclerosis, and Parkinson's disease.
|
28214109 |
2017 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
GWASCAT |
Variant of TREM2 associated with the risk of Alzheimer's disease.
|
23150908 |
2013 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
In this review, we summarize increases in our understanding of the involvement of TREM2 and microglia in AD development that may open new therapeutic strategies targeting the immune system to influence AD pathogenesis.
|
30572908 |
2018 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Coding variants in TREM2 increase risk for Alzheimer's disease.
|
24899047 |
2014 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
TREM2 rare protein coding genetic variants have been linked to AD.
|
29685286 |
2018 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Inflammatory processes involving TREM2 may occur in schizophrenia, as observed in neurocognitive disorders such as AD.
|
26332043 |
2015 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Notably, loss-of-function mutations of either <i>DAP12</i> or <i>TREM2</i> result in a disorder known as Nasu-Hakola disease (NHD); and mutations of these genes have been associated with the risk for Alzheimer's disease (AD), suggesting that TREM2 and DAP12 may regulate common signaling pathways in the disease pathogenesis.
|
28680398 |
2017 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Thus, TREM2 enables microglial responses during AD by sustaining cellular energetic and biosynthetic metabolism.
|
28802038 |
2017 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
(2019) demonstrate opposing effects of CD33 and TREM2 on AD phenotypes, where CD33 deletion promotes neuroprotection in a manner dependent on TREM2.
|
31487521 |
2019 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Thus, TREM2 protects from AD by enabling microglia to surround and alter Aβ plaque structure, thereby limiting neuritic damage.
|
27091843 |
2016 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A rare TREM2 missense mutation (rs75932628-T) was reported to confer a significant Alzheimer's disease (AD) risk.
|
26365049 |
2016 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Rare variants in TREM2 were reported to be associated with significant Alzheimer's disease (AD) risk.
|
27769848 |
2016 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
Down-regulated mRNAs include those encoding complement factor-H (CFH), an SH3-proline-rich multi-domain-scaffolding protein of the postsynaptic density (SHANK3), and the triggering receptor expressed in myeloid/microglial cells (TREM2), as is observed in sporadic AD brain.
|
29637444 |
2018 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
TREM2 plays a critical role in microglial activation, survival, and phagocytosis; however, the pathophysiological role of sTREM2 in AD is not well understood.
|
31413141 |
2019 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
TREM2 variants associated with Alzheimer's disease induce partial loss of function of the TREM2 protein and alter the behaviour of microglial cells, including their response to amyloid plaques.
|
30033062 |
2018 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Two variants in SORL1 and TREM2 were identified that were associated with Alzheimer's disease.
|
31217084 |
2020 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Moreover, the rare TREM2 variant (p.Arg47His), which was considered to be a risk factor for Alzheimer's disease in European descent populations, was not detected in our cohort.
|
29723869 |
2018 |
Alzheimer's Disease
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Our data corroborate and extend previous findings to include an increased frequency of rare heterozygous TREM2 variations in AD and FTD, and show that TREM2 variants may play a role in neurodegenerative diseases in general.
|
24119542 |
2014 |
Alzheimer's Disease
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
TREM2 mRNA levels were significantly higher in AD compared to controls and aMCI.
|
28453482 |
2017 |
Alzheimer's Disease
|
0.700 |
Biomarker
|
disease |
BEFREE |
These findings indicate that TREM2-mediated protection in AD is at least partially dependent on the reservation of microglial phagocytic functions, emphasizing the importance of early therapeutic interventions for this devastating disease.
|
26780455 |
2017 |